nference

SoftwareSeries CCambridge, USnference.ai

Latest round

Series C

Last raised

Dec 2020

Total raised

$109M

Investors

4

About nference

nference, Inc.Founded in 2013 in Cambridge, US, nference, Inc. operates as a software company focused on leveraging healthcare data analytics.nference specializes in transforming real-world healthcare data into actionable insights through its advanced clinical AI platform. The core product offerings include a robust suite of data analytics solutions designed to harmonize disparate healthcare data sources, including radiology images, ECG waveforms, clinical notes, and more. These tools utilize proprietary algorithms and machine learning techniques to extract meaningful variables from unstructured data, enabling healthcare providers and researchers to enhance clinical decision-making and improve patient outcomes. The company's solutions serve a diverse clientele, including healthcare systems, research institutions, and life sciences companies across multiple geographical markets, including North America, Europe, and Asia.nference generates revenue primarily through strategic partnerships and subscription-based models that cater to healthcare systems and life sciences organizations. The company’s transactions typically involve long-term collaborations where clients gain access to its AI-powered analytics platform, which aids in clinical data management and research initiatives. Clients may subscribe to various tiers of service, tailored to their specific needs, which include access to unique clinical biomarkers and data management tools. Each customer engagement may vary in scale and complexity, reflecting the specific requirements of the healthcare institutions or research entities involved.nference, Inc.80 mn, secured on December 15, 2020, to enhance its product offerings and expand into new markets. The company is developing new AI tools designed to further streamline healthcare data analytics, with a launch anticipated in 2022. Additionally, nference aims to penetrate European and Asian markets more deeply by 2023, targeting healthcare systems and institutions that can benefit from improved clinical decision-making and data management.

Who invested in nference

4 investors across 5 rounds

See all investors in nference

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Dec 15, 2020

    Amount

    $55M

    Investors

    Locked

  2. Series B

    Nov 2, 2020

    Amount

    Undisclosed

    Investors

    Locked

  3. Series B

    Jul 23, 2019

    Amount

    $40M

    Investors

    Locked

  4. Series A

    Jun 6, 2018

    Amount

    $11M

    Investors

    Locked

  5. Seed

    Jun 29, 2017

    Amount

    $3.2M

    Investors

    Locked

Questions about nference

Who invested in nference?

nference has 4 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has nference raised?

nference has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did nference last raise money?

nference's most recent round on record is a Series C, in Dec 2020.

What does nference do?

nference is a software company.

Where is nference headquartered?

nference is headquartered in Cambridge, US.

Which VCs invest in companies like nference?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back software companies at nference's stage. Their profiles are linked below.

Raising like nference? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.